echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Microbiology News > NSR(IF=23) Baoli Zhu/Fu Gao, Chinese Academy of Sciences, unveiled the temporal dynamics of drug-resistant enteric salmonella and dominant serum variants in China

    NSR(IF=23) Baoli Zhu/Fu Gao, Chinese Academy of Sciences, unveiled the temporal dynamics of drug-resistant enteric salmonella and dominant serum variants in China

    • Last Update: 2023-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    iNature


    Salmonella enterica is one of the
    most common bacterial pathogens in humans and animals.
    The trend and geographical distribution of drug-resistant Salmonella and dominant serovariants have been systematically studied in Europe and the United States, while relevant studies
    have not been carried out in China.

    On November 29, 2022, Zhu Baoli, Gao Fu, and Xu Xuebin, from the Institute of Microbiology of the Chinese Academy of Sciences, jointly published an online report entitled "The temporal dynamics of antimicrobial-resistant-Salmonella enterica and" in the National Science Review (IF=23).
    Predominant Serovars
    in China", which reveals the temporal dynamics
    of drug-resistant enteric salmonella and major serovariants in China.
    In this study, the "One Health" strategy was used to study
    the spatiotemporal dynamics of the dominant serovariant in China using > 35,000 strains of Salmonella enterica.
    The study
    found that in China, Salmonella typhimurium is the main serum virus that causes human infections, which is consistent with Australia and inconsistent
    with North American and European countries.
    The authors randomly selected 1962 isolates to compare genomics and antimicrobial resistance studies and found that over a 14-year period, each isolate had 1.
    84 and 2.
    69 times
    more antibiotic resistance genes (ARGs) than human and non-human sources, respectively.

    From 2006 to 2019, the proportion of drug-resistant Salmonella strains showed an upward trend, especially the proportion of β-lactams, quinolones, tetracyclines and
    rifampicin-resistant strains.
    In addition, we found a higher diversity of sequence types (STs) of plague compared to other serums, with ST34 from pigs and ST19 from chickens associated
    with isolates that cause stomach infections in children and adults, respectively.
    The results of this study fill the data gap
    of dominant serovariants and drug resistance trends of Salmonella enterica in China.
    These data provide useful information
    for public health decision-makers prioritizing foodborne illness and food safety interventions.


    Salmonella enterica is the leading cause of foodborne illness worldwide, and antibiotic-resistant Salmonella enterica isolates pose a serious threat
    to public health.
    Salmonella enterica consists of 11 subspecies
    .
    Subspecies Salmonella enteritidis typhi (S.
    typhi) and S.
    paratyphi A, B or C can cause typhoid and paratyphoid fever in humans, collectively known as enteric fever, while other serovariants are roughly described as non-Typhi Salmonella (NTS).

    Previous studies have shown that from 1951 to 2007, a total of 322 serotypes
    were detected in China.
    In recent years, S.
    Telkebier, S.
    Telkebier, S.
    Uzaramo and S.
    Telkebier.
    Changwananni was discovered in China by his research colleagues, and they were all identified and reported
    for the first time abroad.
    Although previous meta-analyses have provided a good summary of the prevalence and diversity of Salmonella in five continents (Africa, Americas, Asia, Europe, and Oceania), there are no systematic studies
    of the epidemiology and spatiotemporal dynamics of the dominant serovariant of Salmonella in China 。 To fill this data gap, the study systematically analyzed the characteristics of 35,000 strains of >Enterococcus isolated from human and non-human sources registered in the database of Salmonella local surveillance systems (also known as the Bacterial Learning Alliance) of 23 provinces or municipalities in China over a 14-year period.
    Enterica's basic research and public health risk prediction support
    .
    Temporal and spatial changes of antimicrobial resistance in NTS in China (National Science Review) The emergence and spread of antibiotic resistance (AMR) in the Enterobacteriaceae family pose a serious threat to human and animal health
    .
    Notably, fluoroquinolone-resistant Salmonella and Enterobacteriaceae, which produce ultra-broad-spectrum β-lactamase (ESBL), were classified by WHO as high priority pathogens that pose a risk to human health in 2017, requiring research and development of new antibiotics
    .
    It is estimated that a sustained rise in antibiotic resistance by 2050 will lead to 10 million deaths per year and a reduction in GDP of 2-3.
    5%.

    This work provides the first systematic overview of trends in serovariant prevalence and resistance of Streptococcus enterococci isolated from human and non-human origin in China
    .
    S.
    Typhimurium
    , S.
    Enteritidis and S.
    Typhimurium.
    Derby is the main pathogen
    of Chinese infections.
    Together, the findings represent the largest longitudinal surveillance system for Enterococcus in China and provide valuable public health knowledge
    about trends and distribution of Enterococcus serovariants and AMR.
    This large-scale observational study will provide valuable information
    for food safety intervention, control and prevention of the development and spread of drug-resistant Salmonella in China.

    Original link: https://doi.
    org/10.
    1093/nsr/nwac269
    ENDcontent is [iNature].

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.